Treatment of Rheumatoid Arthritis with Single Dose or Weekly Pulses of Chimaeric Anti‐CD4 Monoclonal Antibody

Scandinavian Journal of Immunology

Volumn 36, Issue 2, 1992, Pages 291-298

  CHOY, E H S ^a   CHIKANZA, I C ^a   KINGSLEY, G H ^a   CORRIGALL, V ^a   PANAYI, G S ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MONOCLONAL ANTIBODY; OKT 4;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTOPENIA; MALE; MONOCYTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RIGOR; T LYMPHOCYTE;

EID: 0026656620     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.1992.tb03102.x     Document Type: Article

References (30)

1. Immunotherapy of rheumatic diseases‐practice and prospects
2. Abnormal distribution of the helper‐inducer and suppressor‐inducer T lymphocyte subsets in the rheumatoid joint
3. Expression of HLA DR DQ and DP antigens and interleukin 2 receptor on synovial fluid T lymphocyte subsets in rheumatoid arthritis, evidence for “frustrated” activation
4. Upregulatcd expression and function of VLA‐4 fibronectin receptors on human activated T cells in rheumatoid arthritis
5. In situ hybridisation of interleukin‐6 in rheumatoid arthritis
6. Genetic basis of rheumatic diseases: HLA antigen, disease manifestations and toxic reactions to drugs
7. The cellular basis of adjuvant arthritis II. Characterisation of the cells mediating passive transfer
8. Passive transfer by cells of type II collagen induced arthritis in rat
9. Prevention of Type II collagen‐induced arthritis by in vivo treatment with anti‐L3T4
10. Monoclonal antibody therapy for arthritis
11. Death of mature T cells by separate ligation of CD4 and the T‐cell receptor for antigen
12. Mechanism of monoclonal antibody facilitated tolerance induction: a possible role for the CD4 (L3T4) and CD11a (LFA‐1) molecule in self‐non‐self discrimination
13. Is tolerance therapy a plausible possibility?
14. Treatment of rheumatoid arthritis with an anti‐CD4 monoclonal antibody
15. Treatment of rheumatoid arthritis with monoclonal CD4 antibody M‐T151
16. Anti‐CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells
17. Utilisation therapeutique d'un anticorps monoclonal anti‐CD4 dans la polyarthrite reumatoide refractaire. Resultats preliminaires
18. Mouse/human chimaeric monoclonal antibody in man: kinetiucs and immune response
19. Treatment of rheumatoid arthritis with chimacric CD4 monoclonal antibody
20. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
21. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatic disease
22. Discriminatory indices of response of patients with rheumatoid arthritis treated with Dpenicillamine
23. Measurement of pain
24. Fixation and longterm storage of human lymphocytes for surface marker analysis by flow cytometry
25. In vivo immunosuppression by pan‐T cell antibodies relates to their isotype and to their C lq uptake
26. Immunosuppressive therapy by monoclonal anti‐T‐lymphocyte subset monoclonal antibodies
27. Use of a chimaeric anti‐CD4 monoclonal antibody in refractory RA
28. Both macrophages and endothelial cells of the human hepatic sinusoid express the CD4 molecule, a receptor for the human immunodeficiency virus
29. Joint uptake of anti‐CD4 in comparison to anti‐human carcino‐embryonic antigen monoclonal antibodies and polyclonal human immunoglobulin in rheumatoid arthritis
30. Elevated levels of circulating tumour necrosis factor‐alpha, interferon‐gamma and interleukin‐2 in systemic reactions induced by anti‐CD4 therapy in patients with rheumatoid arthritis